OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 145
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 145
Showing 1-25 of 145 citing articles:
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 104
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 104
Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
Yang Yang, Lixia Liu, Yu Tian, et al.
Cancer Letters (2024) Vol. 587, pp. 216659-216659
Open Access | Times Cited: 59
Yang Yang, Lixia Liu, Yu Tian, et al.
Cancer Letters (2024) Vol. 587, pp. 216659-216659
Open Access | Times Cited: 59
Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 51
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 51
Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 36
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 36
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy
Zheng Wang, Shuo Pang, Xiaoli Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132579-132579
Closed Access | Times Cited: 24
Zheng Wang, Shuo Pang, Xiaoli Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132579-132579
Closed Access | Times Cited: 24
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 14
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 14
Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives
Tianfeng Li, Milad Ashrafizadeh, Yuru Shang, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103851-103851
Open Access | Times Cited: 31
Tianfeng Li, Milad Ashrafizadeh, Yuru Shang, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103851-103851
Open Access | Times Cited: 31
The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 24
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 24
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy
Shivi Chauhan, Shivani Jaiswal, Vibhuti Jakhmola, et al.
Cancer Letters (2024) Vol. 588, pp. 216766-216766
Open Access | Times Cited: 11
Shivi Chauhan, Shivani Jaiswal, Vibhuti Jakhmola, et al.
Cancer Letters (2024) Vol. 588, pp. 216766-216766
Open Access | Times Cited: 11
The potential influence of melatonin on mitochondrial quality control: a review
Xudan Lei, Zhenni Xu, Lingxiao Huang, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Xudan Lei, Zhenni Xu, Lingxiao Huang, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance
Zhibin Zhang, Z.M. Guo K.L. Gao, Huimin Fang, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 867-888
Closed Access | Times Cited: 6
Zhibin Zhang, Z.M. Guo K.L. Gao, Huimin Fang, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 867-888
Closed Access | Times Cited: 6
CircBIRC6 facilitates the malignant progression via miR-488/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer
Zhiyuan Tang, Jieying Li, Bing Lu, et al.
Pharmacological Research (2024) Vol. 202, pp. 107127-107127
Open Access | Times Cited: 6
Zhiyuan Tang, Jieying Li, Bing Lu, et al.
Pharmacological Research (2024) Vol. 202, pp. 107127-107127
Open Access | Times Cited: 6
Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer
Kazi Rejvee Ahmed, Md. Masudur Rahman, Md. Nahidul Islam, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116497-116497
Open Access | Times Cited: 6
Kazi Rejvee Ahmed, Md. Masudur Rahman, Md. Nahidul Islam, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116497-116497
Open Access | Times Cited: 6
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 6
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 6
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 6
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 6
Yuxiang Li, Jing Bai, Dan Liu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Gold Nanoclusters in Cancer Drug Delivery: Advances and Emerging Applications
Jagdish Singh, Nabil K. Alruwaili, Alhussain Aodah, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106594-106594
Closed Access
Jagdish Singh, Nabil K. Alruwaili, Alhussain Aodah, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106594-106594
Closed Access
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model
Ujjwol Khatri, Mohamed A. Gouda, Shriya Pandey, et al.
Cancer Letters (2025) Vol. 611, pp. 217444-217444
Open Access
Ujjwol Khatri, Mohamed A. Gouda, Shriya Pandey, et al.
Cancer Letters (2025) Vol. 611, pp. 217444-217444
Open Access
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Yanyan Zhang, Zhichao Yang, Yuchen Liu, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Yanyan Zhang, Zhichao Yang, Yuchen Liu, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
Peng Zhao, Shuangshuang Yin, Yuling Qiu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Peng Zhao, Shuangshuang Yin, Yuling Qiu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Apigenin unveiled: an encyclopedic review of its preclinical and clinical insights
Rehnuma Siddiquee, Tarique Mahmood, Valeed Ahmad Ansari, et al.
Discover Plants. (2025) Vol. 2, Iss. 1
Open Access
Rehnuma Siddiquee, Tarique Mahmood, Valeed Ahmad Ansari, et al.
Discover Plants. (2025) Vol. 2, Iss. 1
Open Access
Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor‐on‐a‐chip platform
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
